Latest News

90m African children still exposed to malaria despite more bed nets

Posted 18/11/2008

The use of insecticide-treated bed nets (ITNs) to protect children from malaria has risen six-fold in the past seven years, according to research carried out by the Kenya Unit of the Centre for Tropical Medicine. Dr Abdisalan Noor and Professor Bob Snow participated in the study.

Flu deaths could be reduced thanks to cancer research

Posted 17/11/2008

Cells involved in the body’s immune response to cancer are also implicated in influenza infection and could be targeted in new flu vaccination strategies, scientists at Oxford University have discovered. Professor Vincenzo Cerundolo took part in the study.

Genetic study provides insight into language development

Posted 06/11/2008

The first gene that is associated with a common childhood language disorder, known as specific language impairment (SLI), has been identified by researchers at the Wellcome Trust Centre for Human Genetics, University of Oxford. Dr Simon Fisher let the research.

Researchers at Oxford University announce major new study on depression

Posted 22/10/2008

Researchers from the Wellcome Trust Centre for Human Genetics (WTCHG) at the University of Oxford today announce a major new study into the genetics of major depression in a population of women in China. The five-year project is funded by a £1.4 million grant from the Wellcome Trust. One of the largest studies into depression ever carried out in China, the project is collaboration between the ...

Gene link to poor reading skills

Posted 24/10/2008

In its latest study, researchers at University of Oxford examined the link between a sequence of DNA and reading ability in a sample of 6,000 seven to nine-year old children taking part in a major long-term study known as the Avon Longitudinal Study of Parents and Children (ALSPAC). Dr Silvia Paracchini took part in the study.

Hopes for TB vaccine boosted

Posted 09/10/2008

The world's leading candidate for a tuberculosis vaccine, developed at Oxford University, is to move into the next stage of development. Dr Helen McShane leads this project.

Cancer Research UK award adenovirus process development contract to the CBF

Posted 09/10/2008

Cancer Research UK has awarded the University of Oxford’s Clinical BioManufacturing Facility (CBF) its first commercial process development contract for the production of an adenovirus vector.

New risk factor for prostate cancer

Posted 08/10/2008

Dr Andrew Roddam, from the Cancer Epidemiology Unit, worked with an international team of researchers who found that men with higher levels of IGF-1 were more likely to go on to develop prostate cancer than those with lower levels of the protein.

Vaccine for breast cancer within reach

Posted 06/10/2008

Professor Valerie Beral of Oxford University, who leads the Million Women's Study into the causes of the disease, told the Guardian the study had put beyond doubt what had long been guessed - that many breast cancers are caused by the absence of hormonal changes connected with childbirth.

Duke of York visits Vietnam unit

Posted 15/09/2008

His Royal Highness The Duke of York, KG visited the Oxford University Clinical Research Unit in Vietnam on 10 September during a three-day official visit to celebrate 35 years of diplomatic ties between the United Kingdom and Vietnam.

If you have news or events that you would like to be added to this website, please email us details. If possible, please include a picture and links to further information.